Nathaniel E. David
2017
In 2017, Nathaniel E. David earned a total compensation of $2.6M as President at Unity Biotechnology.
Compensation breakdown
Non-Equity Incentive Plan | $169,575 |
---|---|
Option Awards | $1,973,679 |
Salary | $425,000 |
Total | $2,568,254 |
David received $2M in option awards, accounting for 77% of the total pay in 2017.
David also received $169.6K in non-equity incentive plan and $425K in salary.
Rankings
In 2017, Nathaniel E. David's compensation ranked 4,314th out of 14,666 executives tracked by ExecPay. In other words, David earned more than 70.6% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 4,314 out of 14,666 | 71st |
Division Manufacturing | 1,512 out of 5,772 | 74th |
Major group Chemicals And Allied Products | 435 out of 2,075 | 79th |
Industry group Drugs | 333 out of 1,731 | 81st |
Industry Pharmaceutical Preparations | 263 out of 1,333 | 80th |
Source: SEC filing on April 26, 2019.
David's colleagues
We found one more compensation record of an executive who worked with Nathaniel E. David at Unity Biotechnology in 2017.
2017
Keith Leonard
Unity Biotechnology